Pharmacological protection of NSAID-induced intestinal permeability in the rat: Effect of tempo and metronidazole as potential free radical scavengers

Human and Experimental Toxicology

Volumn 16, Issue 7, 1997, Pages 345-349

  Davies, Neal M ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

51Cr EDTA; Intestinal permeability; Metronidazole; Nitric oxide; Non steroidal antiinflammatory drug small intestine

Indexed keywords

EDETATE CHROMIUM CR 51; FLURBIPROFEN; INDOMETACIN; METRONIDAZOLE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTEROPATHY; INTESTINE MUCOSA PERMEABILITY; INTESTINE ULCER; MALE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RAT; TIME;

ANIMALIA; LETHRINIDAE;

EID: 0030841605     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600701     Document Type: Article

References (35)

1. Rainsford KD. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scandinavian Journal of Gastroenterology 1989; 24: 9-16.
2. Allison MC et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. New England Journal of Medicine 1992; 327: 751-756.
3. Bjarnason I, Hayllar J, Macpherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 1993; 104: 832-847.
4. Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Diseases of the Colon and Rectum 1995; 38: 1311-1321.
5. Fletcher BS, Kujubu DA, Perrin DM, Herschman HR. Structure of mitogen inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. Journal of Biological Chemistry 1992; 267: 4338-4344.
6. Wallace JL, Cirino G. The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends in Pharmacological Sciences 1994; 15: 405-406.
7. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. American Journal of Physiology 1992; 262: G1138-G1142.
8. May GR, Crook P, Moore PK, Page CP. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. British Journal of Pharmacology 1991; 102: 759-766.
9. Rachmilewitz D, Karmeli F, Okon E, Samuni A. A novel antiulcerogenic stable radical prevents gastric mucosal lesions in rats. Gut 1994; 35: 1181-1188.
10. Wallace JL et al. A diclofenac derivative without ulcerogenic properties. European Journal of Pharmacology 1994; 257: 249-255.
11. Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to rat gastric mucosa. British Journal of Pharmacology 1993; 108: 73-79.
12. Ford J, Martin SW, Houston JB. Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat. Journal of Pharmacological and Toxicological Methods 1995; 34: 9-16.
13. 51Cr-ethylenediaminetetraacetic acid absorption test. Scandinavian Journal of Gastroenterology 1989; 24: 351-358.
14. Davies NM, Wright MR, Jamali F. Antiinflammatory drug-induced small intestinal permeability. The Rat Is a Suitable Model. Pharmaceutical Research 1994; 11: 1652-1656.
15. Kent TH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. American Journal of Pathology 1969; 54: 237-245.
16. Robert A, Asano T. Resistance of germ free rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 333-341.
17. Melarange R et al. A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free rats. Alimentary Pharmacology and Therapeutics 1992; 6: 67-77.
18. Day TK. Intestinal perforation associated with osmotic slow release indomethacin capsules. British Medical Journal 1983; 287: 1672.
19. Davies NM, Jamali F, Skeith KJ. Non-steroidal antiinflammatory drug (NSAID)-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritis. Arthritis and Rheumatism 1996; 39: 321-324.
20. Saverymuttu SH, Thomas A, Grundy A, Maxwell JD. Ileal stricturing after long-term indomethacin treatment. Postgrad Medical Journal 1986; 62: 967-968.
21. Speed CA, Bramble MG, Corbett WA, Haslock I. Nonsteroidal anti-inflammatory induced diaphragm disease of the small intestine: complexities of diagnosis and management. British Journal of Rheumatology 1994; 33: 778-780.
22. Sturges HF, Krone CL. Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy. American Journal of Gastroenterology 1973; 59: 162-169.
23. Bjarnason I et al. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal antiinflammatory drug induced enteropathy. Gut 1992; 33: 1204-1208.
24. Collins AJ, Reid J, Soper CJ, Notarianni LJ. Characteristics of ulcers of the small bowel induced by non-steroidal anti-inflammatory drugs in the rat: Implications for clinical practice. British Journal of Rheumatology 1995; 34: 727-731.
25. Whittle BJR. Temporal relationship between cycloxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-98.
26. Davies GR, Wilkie ME, Rampton DS. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Digestive Diseases and Sciences 1993; 38: 417-425.
27. Abramson SB, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism 1991; 32: 1-8.
28. Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents and Actions 1985; 17: 484-488.
29. Kubes P, Szuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Science USA 1991; 88: 4651-4659.
30. Milks LC, Conyers GP, Cramer EB. The effect of neutrophil migration on epithelial permeability. The Journal of Cell Biology 1986; 103: 2729-2738.
31. Akamatsu H et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: A possible mechanism of action of metronidazole in rosacea and acen. Archives of Dermatology Research 1991; 282: 449-454.
32. Rainsford KD. The effects of 5-lipoxygenase inhibitors and leucotriene antagonists on the development of gastric lesions induced by non-steroidal anti-inflammatory drugs in mice. Agents and Actions 1987; 21: 316-319.
33. Salvemni D et al. Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Science USA 1993; 90: 7240-7244.
34. Sosnovsky G. A critical evaluation of the present status of toxicity of aminoxyl radicals. Journal of Pharmaceutical Sciences 1992; 81: 496-499.
35. Turner P et al. Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem clinical isolate of Bacteroides fragilis. Lancet 1995; 345: 1275-1277.